<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0214800.ref060">
 <label>60</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Hulgan</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Raffanti</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Kheshti</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Blackwell</surname>
   <given-names>RB</given-names>
  </name>, 
  <name>
   <surname>Rebeiro</surname>
   <given-names>PF</given-names>
  </name>, 
  <name>
   <surname>Barkanic</surname>
   <given-names>G</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts &gt;350 lymphocytes/mm3</article-title>. 
  <source>J Infect Dis</source>. 
  <year>2005</year>;
  <volume>192</volume>(
  <issue>6</issue>): 
  <fpage>950</fpage>â€“
  <lpage>957</lpage>. 
  <pub-id pub-id-type="doi">10.1086/432955</pub-id>
  <?supplied-pmid 16107946?>
  <pub-id pub-id-type="pmid">16107946</pub-id>
 </mixed-citation>
</ref>
